Form 4 for RLAY Relay Therapeutics, Inc.

Accepted 2026-01-29 00:00:00 ET · period of report 2026-01-27 · accession 0001193125-26-029412 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2026-01-29	2026-01-27+	RLAY	Rahmer Peter	See remarks	S - Sale	$7.71	-13.0K	276.6K	-5%	-$100.5K
	2026-01-29	2025-12-31	RLAY	Rahmer Peter	See remarks	A - Grant	$2.99	+994	338.5K	+0.3%	+$2,972

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2026-01-27	S	D	11,684	$7.62	277,964	D	—	—	(F4) Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 42,394 shares of RSUs on January 26, 2026. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs. (F5) Includes 17,710 shares underlying RSUs.
2	Common	Common Stock	2025-12-31	A	A	994	$2.99	338,463	D	—	—	(F2) In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on July 1, 2025. (F3) Includes 108,919 shares underlying restricted stock units ("RSUs").
3	Common	Common Stock	2026-01-28	S	D	1,354	$8.45	276,610	D	—	—	(F6) Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 5,506 shares of RSUs on January 27, 2026. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs. (F7) Includes 12,204 shares underlying RSUs.